Atlas Trials

A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)

Clinical trial NCT03449147 · COMPLETED

Trial details

NCT number
NCT03449147
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Cough
Start date
2018-03-15
Primary completion
2020-08-20
Enrollment
1317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.